Scohia Pharma is a biotech firm that specializes in synthetic and pharmacology research, clinical development, and collaboration services.
Scohia Pharma has raised $442.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
Scohia Pharma's investors include SBI Investment, Beyond Next Ventures, Takeda, KSP, DCI Partners.
Scohia Pharma is headquartered in Fujisawa, Japan.
Scohia Pharma is a biotech firm that specializes in synthetic and pharmacology research, clinical development, and collaboration services.
Scohia Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scohia Pharma — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/scohia-pharma. Accessed October 15, 2026.
VCBacked. (2026). Scohia Pharma — Funding & Investors. Retrieved October 15, 2026, from https://www.vcbacked.co/company/scohia-pharma
{{cite web |title=Scohia Pharma — Funding & Investors |url=https://www.vcbacked.co/company/scohia-pharma |website=VCBacked |access-date=October 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated